Correlation analysis showed that USP20 expression positively correlated with the expression of MRP1, MRP3 and MRP5 genes (Figure 6B), suggesting that USP20 expression may be associated with drug resistance in CRC. This evidence concerns the gene USP20 and colorectal carcinoma.